Literature DB >> 36177354

Spirometric values associated with clinical form and risk of death and stroke in chagasic patients.

Nickson Melo De Morais1, Micássio Fernandes De Andrade2, Valéria Duarte De Almeida1, Lara Candice Costa De Morais Leonez3, Cléber Mesquita De Andrade2,3, Christiane Medeiros Bezerra4, Ellany Gurgel Cosme Do Nascimento2,3, José Veríssimo Fernandes4, Thales Allyrio Araújo De Medeiros Fernandes2,3.   

Abstract

The aim of the present study was to compare pulmonary function among patients with different clinical forms and scores for risk of death and stroke. Patients were recruited from the Chagas Disease Ambulatory Service at the University of Rio Grande do Norte State (Mossoró, Brazil). The evaluation of pulmonary function was performed through spirometry techniques using a digital spirometer, and information about the clinical forms (cardiac, cardiodigestive, digestive and undetermined) and scores for risk of death (Rassi's risk-of-death score) and stroke was subsequently collected. Upon completion of the evaluation, comparisons of the values obtained between the groups for different clinical forms, risk stratification of stroke and Rassi's risk-of-death were made. The study cohort consisted of 72 patients. Individuals with a low risk of death had significantly higher values in the Tiffeneau index and individuals with a low risk of stroke presented with higher percentage values for forced vital capacity and forced expiratory volume in 1 sec. In addition, individuals with heart disease had worse percentage values for FVC and FEV1. In conclusion, the results showed that spirometry was an effective analytical technique and was associated with clinical forms, and death and stroke risk scores, in patients with Chagas disease, adding an important prognostic tool to those currently available.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  chagas cardiomyopathy; chagas disease; prognosis; pulmonary function test; spirometry

Year:  2022        PMID: 36177354      PMCID: PMC9501762          DOI: 10.3892/br.2022.1571

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  30 in total

Review 1.  Sudden death in Chagas' disease.

Authors:  A Rassi; S G Rassi; A Rassi
Journal:  Arq Bras Cardiol       Date:  2001-01       Impact factor: 2.000

2.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

3.  Chagas disease in Latin America: an epidemiological update based on 2010 estimates.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2015-02-06

4.  [Brazilian Consensus on Chagas Disease, 2015].

Authors:  João Carlos Pinto Dias; Alberto Novaes Ramos; Eliane Dias Gontijo; Alejandro Luquetti; Maria Aparecida Shikanai-Yasuda; José Rodrigues Coura; Rosália Morais Torres; José Renan da Cunha Melo; Eros Antonio de Almeida; Wilson de Oliveira; Antônio Carlos Silveira; Joffre Marcondes de Rezende; Fabiane Scalabrini Pinto; Antonio Walter Ferreira; Anis Rassi; Abílio Augusto Fragata; Andréa Silvestre de Sousa; Dalmo Correia; Ana Maria Jansen; Glaucia Manzan Queiroz Andrade; Constança Felícia De Paoli de Carvalho Britto; Ana Yecê das Neves Pinto; Anis Rassi; Dayse Elisabeth Campos; Fernando Abad-Franch; Silvana Eloi Santos; Egler Chiari; Alejandro Marcel Hasslocher-Moreno; Eliane Furtado Moreira; Divina Seila de Oliveira Marques; Eliane Lages Silva; José Antonio Marin-Neto; Lúcia Maria da Cunha Galvão; Sergio Salles Xavier; Sebastião Aldo da Silva Valente; Noêmia Barbosa Carvalho; Alessandra Viana Cardoso; Rafaella Albuquerque E Silva; Veruska Maia da Costa; Simone Monzani Vivaldini; Suelene Mamede Oliveira; Vera da Costa Valente; Mayara Maia Lima; Renato Vieira Alves
Journal:  Epidemiol Serv Saude       Date:  2016-06

5.  Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease.

Authors:  D E O'Donnell; S M Revill; K A Webb
Journal:  Am J Respir Crit Care Med       Date:  2001-09-01       Impact factor: 21.405

6.  Prevention strategies of cardioembolic ischemic stroke in Chagas' disease.

Authors:  Andréa Silvestre de Sousa; Sérgio Salles Xavier; Gabriel Rodriguez de Freitas; Alejandro Hasslocher-Moreno
Journal:  Arq Bras Cardiol       Date:  2008-11       Impact factor: 2.000

7.  Percent emphysema, airflow obstruction, and impaired left ventricular filling.

Authors:  R Graham Barr; David A Bluemke; Firas S Ahmed; J Jeffery Carr; Paul L Enright; Eric A Hoffman; Rui Jiang; Steven M Kawut; Richard A Kronmal; João A C Lima; Eyal Shahar; Lewis J Smith; Karol E Watson
Journal:  N Engl J Med       Date:  2010-01-21       Impact factor: 91.245

8.  The prognostic significance of lung function in stable heart failure outpatients.

Authors:  Louis Lind Plesner; Morten Dalsgaard; Morten Schou; Lars Køber; Jørgen Vestbo; Erik Kjøller; Kasper Iversen
Journal:  Clin Cardiol       Date:  2017-09-13       Impact factor: 2.882

9.  Exercise performance and skeletal muscles in patients with advanced Chagas disease.

Authors:  María Montes de Oca; Sonia H Torres; José G Loyo; Francia Vazquez; Noelina Hernández; Begoña Anchustegui; Juan J Puigbó
Journal:  Chest       Date:  2004-04       Impact factor: 9.410

10.  Global strategy for asthma management and prevention: GINA executive summary.

Authors:  E D Bateman; S S Hurd; P J Barnes; J Bousquet; J M Drazen; J M FitzGerald; P Gibson; K Ohta; P O'Byrne; S E Pedersen; E Pizzichini; S D Sullivan; S E Wenzel; H J Zar
Journal:  Eur Respir J       Date:  2008-01       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.